SEC ownership of 10x Genomics, Inc.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001770787.

Comparable stake leader

FMR LLC

Disclosed value leader

PRICE T ROWE ASSOCIATES INC /MD/

Comparable rows

50/50

Latest evidence

09 Sep 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
50 of 50
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
FMR LLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
09 Sep 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001770787
Issuer location
Pleasanton, CA

Ownership snapshot

Top shareholders of 10x Genomics, Inc. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
PRICE T ROWE ASSOCIATES I...
Comparable rows
50/50
Latest evidence
09 Sep 2026
13F 13D/G 3/4/5 Lead comparable stake: 16% 13D/G row: FMR LLC Showing 1-8 of 50 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 16%.

50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 16%
PRICE T ROWE ASSOCIATES INC /MD/ 12%
VANGUARD GROUP INC 12%
ARK Investment Management LLC 8.6%
BlackRock, Inc. 7.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 50 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F 13D/G
Company
16%
from 13D/G
$675,906,044
17,629,266 shares
30 Jun 2026
PRICE T ROWE ASSOCIATES INC /MD/
13D/G 13F
T. Rowe Price Associates, Inc. · Company
12%
$811,042,155
14,044,020 shares
$0 31 Aug 2026
VANGUARD GROUP INC
13D/G
The Vanguard Group
12%
$155,176,941
13,274,332 shares
$0 30 Sep 2025
ARK Investment Management LLC
13D/G 13F
Company
8.6%
$383,517,244
10,003,058 shares
-$72,245,519 30 Jun 2026
BlackRock, Inc.
13F 13D/G
Company
7.6%
from 13D/G
$414,228,044
10,804,070 shares
30 Jun 2026
Sumitomo Mitsui Trust Group, Inc.
13F 13D/G
Company
4.7%
from 13D/G
$160,821,999
4,194,627 shares
30 Jun 2026
Amova Asset Management Americas, Inc.
13F 13D/G
Company
4.7%
from 13D/G
$160,741,102
4,192,517 shares
30 Jun 2026
MILLENNIUM MANAGEMENT LLC
13D/G 13F
Company
2.7%
$36,913,960
3,060,859 shares
-$29,821,474 30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

Net insider flow leans to selling over the last 12 months. Net value: -$14,381,190.

Buys
$0
Insiders: 0
Sells
$14,381,190
Insiders: 6
Net
-$14,381,190
Shares: -351,059
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 351,059
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 191,884 $0 $10,967,767 -$10,967,767
3-6 0 75,586 $0 $1,773,167 -$1,773,167
6-9 0 50,157 $0 $1,005,105 -$1,005,105
9-12 0 33,432 $0 $635,151 -$635,151

Reporting owners

Insider holders from Forms 3/4/5

Showing 1-14 of 14 reporting-owner rows connected to 10x Genomics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.

Rows
14
Largest Forms 3/4/5 holder
Bryan E. Roberts
Net 12M change
-$14,381,190
Latest report
09 Sep 2026
Name Relationship Holdings Value Past Year Net Change Change % Valuation Report Date
Bryan E. Roberts Director $195,830,277 Mixed 14 Jun 2023
Serge Saxonov Chief Executive Officer, Director $107,062,890 -$4,788,655 -4.3% Mixed 01 Sep 2026
Benjamin J. Hindson Title: President and Chief Scientific Officer, Director $30,766,987 -$1,457,001 -4.5% Filing P/S 24 Aug 2026
Adam Taich Chief Financial Officer $20,643,786 -$4,838,786 -19% Filing P/S 09 Sep 2026
John R. Stuelpnagel Director $20,562,261 -$2,390,127 -10% Filing P/S 03 Sep 2026
Bradford Crutchfield former officer $4,438,548 Mixed 29 Jul 2022
Mathai Mammen Director $4,380,943 Mixed 11 Jun 2024
James Wilbur Chief Commercial Officer $3,804,287 Mixed 22 Nov 2023
Justin J. McAnear Former Chief Financial Officer $3,227,199 Filing P/S 22 Aug 2024
Shehnaaz Suliman Director $1,887,968 -$327,234 -15% Filing P/S 24 Aug 2026
Alan Mateo Director $1,823,168 Mixed 04 Jun 2026
Sarah A. Teichmann Director $1,603,514 -$579,387 -27% Filing P/S 13 Aug 2026
Sridhar Kosaraju Director $1,449,541 Mixed 04 Jun 2026
Kimberly J. Popovits Director $794,957 Mixed 04 Jun 2026

Recent insider transactions for 10x Genomics, Inc.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
Adam Taich TXG Class A Common Stock Sale -12.8% $2,995,470 $64.57 -46,388 316,344 09 Sep 2026 Direct
John R. Stuelpnagel TXG Class A Common Stock Sale -5.74% $1,235,072 $61.75 -20,000 328,436 03 Sep 2026 Direct
Serge Saxonov TXG Class A Common Stock Gift -0.01% -100 1,075,249 01 Sep 2026 Direct
Serge Saxonov TXG Class A Common Stock Sale -0.97% $667,901 $63.69 -10,486 1,075,349 26 Aug 2026 Direct
Serge Saxonov TXG Class A Common Stock Sale -1.68% $1,168,775 $63.02 -18,545 1,085,835 24 Aug 2026 Direct
Adam Taich TXG Class A Common Stock Sale -4.52% $1,081,853 $63.02 -17,166 362,732 24 Aug 2026 Direct
Benjamin J. Hindson TXG Class A Common Stock Sale -2.75% $870,860 $63.02 -13,818 488,182 24 Aug 2026 Direct
Shehnaaz Suliman TXG Class A Common Stock Sale -6.96% $140,478 $63.65 -2,207 29,515 24 Aug 2026 Direct
Serge Saxonov TXG Class A Common Stock Gift -0.36% -4,000 1,104,380 20 Aug 2026 Direct
Sarah A. Teichmann TXG Class A Common Stock Sale -7.49% $129,902 $57.15 -2,273 28,058 14 Aug 2026 Direct
Sarah A. Teichmann TXG Class A Common Stock Sale -14.8% $302,377 $57.29 -5,278 30,331 13 Aug 2026 Direct
John R. Stuelpnagel TXG Class A Common Stock Sale -5.43% $1,155,055 $57.75 -20,000 348,436 11 Aug 2026 Direct
Serge Saxonov TXG Class A Common Stock Sale -2.64% $1,033,269 $34.44 -30,000 1,108,380 22 Jun 2026 Direct
Shehnaaz Suliman TXG Class A Common Stock Sale -15.3% $186,756 $32.63 -5,723 31,722 16 Jun 2026 Direct
Sarah A. Teichmann TXG Class A Common Stock Award 33% 8,829 35,609 04 Jun 2026 Direct
Shehnaaz Suliman TXG Class A Common Stock Award 30.8% 8,829 37,445 04 Jun 2026 Direct
John R. Stuelpnagel TXG Class A Common Stock Award 2.46% 8,829 368,436 04 Jun 2026 Direct
Kimberly J. Popovits TXG Class A Common Stock Award 30.8% 8,829 37,445 04 Jun 2026 Direct
Alan Mateo TXG Class A Common Stock Award 11.5% 8,829 85,877 04 Jun 2026 Direct
Sridhar Kosaraju TXG Class A Common Stock Award 15.6% 8,829 65,278 04 Jun 2026 Direct
Serge Saxonov TXG Class A Common Stock Sale -0.93% $264,833 $24.71 -10,718 1,138,380 26 May 2026 Direct
Serge Saxonov TXG Class A Common Stock Sale -1.56% $444,224 $24.44 -18,175 1,149,098 22 May 2026 Direct
Benjamin J. Hindson TXG Class A Common Stock Sale -2.26% $283,399 $24.44 -11,595 502,000 22 May 2026 Direct
Adam Taich TXG Class A Common Stock Sale -3.82% $369,018 $24.44 -15,098 379,898 22 May 2026 Direct
Serge Saxonov TXG Class A Common Stock Sale -0.43% $122,784 $24.56 -5,000 1,167,273 14 Apr 2026 Direct
Serge Saxonov TXG Class A Common Stock Sale -0.42% $97,612 $19.52 -5,000 1,172,273 24 Mar 2026 Direct
Serge Saxonov TXG Class A Common Stock Sale -0.84% $191,297 $19.13 -10,000 1,177,273 23 Mar 2026 Direct
Serge Saxonov TXG Class A Common Stock Gift -0.23% -2,750 1,200,917 03 Mar 2026 Direct
Serge Saxonov TXG Class A Common Stock Sale -1.32% $367,097 $22.73 -16,152 1,203,667 02 Mar 2026 Direct
Serge Saxonov TXG Class A Common Stock Award 14.9% 157,895 1,219,819 26 Feb 2026 Direct
Benjamin J. Hindson TXG Class A Common Stock Award 20.9% 88,816 513,595 26 Feb 2026 Direct
Adam Taich TXG Class A Common Stock Award 37% 106,579 394,996 26 Feb 2026 Direct
Sarah A. Teichmann TXG Class A Common Stock Sale -22.1% $147,108 $19.41 -7,579 26,780 25 Feb 2026 Direct
Serge Saxonov TXG Class A Common Stock Sale -0.9% $178,928 $18.58 -9,632 1,061,924 23 Feb 2026 Direct
Adam Taich TXG Class A Common Stock Sale -3.02% $166,593 $18.58 -8,968 288,417 23 Feb 2026 Direct
Benjamin J. Hindson TXG Class A Common Stock Sale -1.81% $145,379 $18.58 -7,826 424,779 23 Feb 2026 Direct
Serge Saxonov TXG Class A Common Stock Options Exercise 4.89% 50,000 1,071,556 05 Jan 2026 Direct
Serge Saxonov TXG Stock Option (right to buy) Options Exercise -100% -50,000 0 05 Jan 2026 Direct
Adam Taich TXG Class A Common Stock Sale -3.84% $225,852 $19.00 -11,888 297,385 24 Nov 2025 Direct
Benjamin J. Hindson TXG Class A Common Stock Sale -1.88% $157,363 $19.00 -8,283 432,605 24 Nov 2025 Direct
Serge Saxonov TXG Class A Common Stock Sale -1.28% $251,936 $19.00 -13,261 1,021,556 24 Nov 2025 Direct
Serge Saxonov TXG Class A Common Stock Gift -0.09% -900 1,034,817 12 Sep 2025 Direct
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .